A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Zocor (simvastatin): Label Change – New Restrictions, Contraindications, and Dose Limitations. According to the Food & Drug Administration FDA’s MedWatch:
Patients taking simvastatin 80 mg daily have an increased risk of myopathy, including rhabdomyolysis, which can damage the kidneys and lead to kidney failure which can be fatal.
For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Zocor (simvastatin): Label Change – New Restrictions, Contraindications, and Dose Limitations.
To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.
If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.